Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: irinotecan hydrochloride
- DRUG: raltitrexed
Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators